Drugmaker GSK stopped making asthma inhaler Flovent earlier this year. That’s left patients struggling to find other medication their insurance will cover.Children have been hit especially hard.

Boston Children's Hospital saw a precipitous drop in cases during the spring shutdown, and the trend continues. Researchers are asking why — and what it would take to keep up the change post-pandemic.